-

Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in Technology, Media, and Telecom (TMT) Sector - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in Technology, Media, and Telecom (TMT) Sector - Thematic Research" report has been added to ResearchAndMarkets.com's offering.

This report analyzes the disruptive themes that have driven M&A activity in 2021 in the TMT Sector

M&A deal value grew by 22% from $1,039 billion in 2020 to $1,270 billion in 2021. In terms of deal volume, 2021 saw 12,585 deals compared to 9,942 in the previous year, recording a growth of 27%. There were 276 billion-dollar-plus M&A deals in the TMT sector in 2021, compared to 188 in the previous year.

Scope

  • This report provides an overview of merger and acquisition activity globally in 2021 in TMT Sector
  • It identifies the themes driving most notable to deals announced in 2021 in the TMT Sector

Reasons to Buy

  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in TMT sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.

Key Topics Covered:

  • Global M&A deals in 2021 - Key takeaways
  • Review of global M&A deals in 2021
  • Themes driving global M&A deals in 2021
  • Appendices

Companies Mentioned

  • Oracle Corp
  • American Tower
  • Emerson
  • Polestar Volvo
  • Intuit
  • NortonLifeLock
  • Square
  • The Blackstone Group
  • Amazon
  • Discovery
  • Prosus
  • Thoma Bravo
  • Microsoft
  • Hitachi
  • ironSource
  • Rogers Communications
  • Peraton
  • OptumInsight
  • Cerner Corp
  • CoreSite Realty
  • McAfee
  • Aspen Technology
  • Gores
  • The Rocket Science Group
  • Avast
  • Afterpay
  • QTS Realty Trust
  • Metro-Goldwyn-Mayer
  • Warner Media
  • Naspers
  • Proofpoint
  • Nuance Communications
  • China Tower
  • GlobalLogic
  • Shaw Communications
  • Perspecta
  • Change Healthcare
  • Symbotic
  • Vista Equity
  • TPG Capital
  • Equifax
  • Qualtrics International
  • Symphony Technology Group
  • KKR & Co
  • Clayton, Dubilier & Rice
  • IBM
  • Panasonic
  • Synnex
  • Rockley Photonics
  • Doma
  • Janus Henderson Group
  • Match Group
  • Evergreen Coast Capital
  • Veritas Capital
  • Boston Scientific
  • Teledyne Technologies
  • SVF Investment III
  • Blue Prism Group
  • Appriss Insights
  • Clarabridge
  • Medallia
  • FireEye
  • Cloudera
  • Turbonomic
  • Blue Yonder
  • Tech Data
  • SC Health
  • Capitol Investment
  • Yandex
  • Hyperconnect
  • Cubic
  • Preventice
  • FLIR Systems
  • TransUnion
  • 888
  • PayU
  • Pershing Square and affiliates
  • Penn National Gaming
  • Netmarble Games
  • Platinum Equity
  • Altice UK
  • Pershing Square Tontine
  • Amazon.com
  • TF1 Group
  • Clarivate
  • Apollo Global
  • Gray Television
  • Hufffpost Ballys Corporation
  • Beijing ByteDance Technology
  • Electronic Arts
  • NeuStar
  • Caesars Entertainment
  • IndiaIdeas.com
  • Universal Music Group
  • theScore
  • SpinX Games
  • McGraw Hill Companies
  • BT Group
  • Metropole Television
  • ProQuest
  • Verizon Media
  • Local Media Group
  • Santa Cruz Works
  • Gamesys Group
  • Shanghai Mutong Technology
  • AT&T
  • Glu Mobile
  • Nitro Bidco

For more information about this report visit https://www.researchandmarkets.com/r/h7ak4j

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom